ReviewDiagnostic cytopathology2026
Cytopathology Trends in Nepal-Historic and Current Practices and Future Directions.
Review in Diagnostic cytopathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cytopathology in Nepal has expanded considerably over recent decades, playing a key role in the diagnosis of both malignancies and infectious diseases. This article reviews the historical evolution, current practices, specimen types, processing techniques, and reporting systems in Nepal. It also outlines cytopathology training, workforce development, and cervical cancer screening initiatives. Despite this progress, access to advanced ancillary techniques such as immunocytochemistry and molecular testing remains limited, with reliance on referral laboratories. Ongoing challenges include resource constraints, uneven infrastructure, and limited subspecialty training opportunities. Strengthening diagnostic capacity through expanded infrastructure, quality assurance, and targeted training will be essential for future growth. Due to limited published data, some observations are based on the authors' experience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.